Denteric
Melbourne
About Denteric
Denteric is developing a vaccine based on research conducted at the University of Melbourne, with collaborative support from CSL Limited, to fight the disease and will receive the money in three parts each year from 2019 to 2021.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.5M
- Funding stage: Early Stage Venture
- Last round: Grant (Jul 2022)
- Website: denteric.com
- Phone: [email protected]
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/denteric-159482 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.